# RLI Corp: financial statements, quarterly

RLI · NYSE · CIK 84246 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rli.md) · [Financials](/companies/rli/financials.md) · [Filings](/companies/rli/filings.md) · [Insiders](/companies/rli/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rli/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [434 d](/filings/0001104659-26-018013.md) | [445](/filings/0001558370-25-005531.md) | [416](/filings/0001558370-25-009525.md) | [470](/filings/0001104659-25-101474.md) | [439 d](/filings/0001104659-26-018013.md) | [408](/filings/0001104659-26-048474.md) | [500](/filings/0001104659-26-086576.md) | [509](/filings/0001104659-26-117864.md) | [466 d](/filings/0001104659-26-018013.md) | [424](/filings/0001104659-26-048474.md) | [576](/filings/0001104659-26-086576.md) | [477](/filings/0001104659-26-117864.md) |
| Income tax | $m | [28.8 d](/filings/0001104659-26-018013.md) | [32.1](/filings/0001558370-25-005531.md) | [21.3](/filings/0001558370-25-009525.md) | [21.8](/filings/0001104659-25-101474.md) | [6.6 d](/filings/0001104659-26-018013.md) | [15.4](/filings/0001104659-26-048474.md) | [32.2](/filings/0001104659-26-086576.md) | [32.6](/filings/0001104659-26-117864.md) | [22.4 d](/filings/0001104659-26-018013.md) | [12.5](/filings/0001104659-26-048474.md) | [42.7](/filings/0001104659-26-086576.md) | [19.1](/filings/0001104659-26-117864.md) |
| Net income | $m | [115 d](/filings/0001104659-26-018013.md) | [128](/filings/0001104659-25-101474.md) | [82.0](/filings/0001104659-25-101474.md) | [95.0](/filings/0001104659-25-101474.md) | [40.9 d](/filings/0001104659-26-018013.md) | [63.2](/filings/0001104659-26-117864.md) | [124](/filings/0001104659-26-117864.md) | [125](/filings/0001104659-26-117864.md) | [91.2 d](/filings/0001104659-26-018013.md) | [54.9](/filings/0001104659-26-117864.md) | [168](/filings/0001104659-26-117864.md) | [81.0](/filings/0001104659-26-117864.md) |
| Diluted EPS | $ per share | not reported | [1.39](/filings/0001558370-25-005531.md) | [0.89](/filings/0001558370-25-009525.md) | [1.03](/filings/0001104659-25-101474.md) | not reported | [0.68](/filings/0001104659-26-048474.md) | [1.34](/filings/0001104659-26-086576.md) | [1.35](/filings/0001104659-26-117864.md) | not reported | [0.60](/filings/0001104659-26-048474.md) | [1.82](/filings/0001104659-26-086576.md) | [0.88](/filings/0001104659-26-117864.md) |
| Basic EPS | $ per share | not reported | [1.40](/filings/0001558370-25-005531.md) | [0.90](/filings/0001558370-25-009525.md) | [1.04](/filings/0001104659-25-101474.md) | not reported | [0.69](/filings/0001104659-26-048474.md) | [1.35](/filings/0001104659-26-086576.md) | [1.36](/filings/0001104659-26-117864.md) | not reported | [0.60](/filings/0001104659-26-048474.md) | [1.83](/filings/0001104659-26-086576.md) | [0.88](/filings/0001104659-26-117864.md) |

- Revenue: us-gaap:Revenues
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [36.4](/filings/0001558370-25-001301.md) | [44.6](/filings/0001558370-24-005567.md) | [50.0](/filings/0001558370-24-010016.md) | [60.6](/filings/0001558370-24-013506.md) | [39.8](/filings/0001104659-26-018013.md) | [27.1](/filings/0001558370-25-005531.md) | [21.4](/filings/0001558370-25-009525.md) | [52.6](/filings/0001104659-25-101474.md) | [51.6](/filings/0001104659-26-117864.md) | [49.1](/filings/0001104659-26-048474.md) | [32.1](/filings/0001104659-26-086576.md) | [46.2](/filings/0001104659-26-117864.md) |
| Total assets | $m | [5,180](/filings/0001558370-25-001301.md) | [5,338](/filings/0001558370-24-005567.md) | [5,512](/filings/0001558370-24-010016.md) | [5,792](/filings/0001558370-24-013506.md) | [5,629](/filings/0001104659-26-018013.md) | [5,729](/filings/0001558370-25-005531.md) | [5,991](/filings/0001558370-25-009525.md) | [6,247](/filings/0001104659-25-101474.md) | [6,161](/filings/0001104659-26-117864.md) | [6,402](/filings/0001104659-26-048474.md) | [6,413](/filings/0001104659-26-086576.md) | [6,446](/filings/0001104659-26-117864.md) |
| Total liabilities | $m | [3,767](/filings/0001558370-25-001301.md) | [3,818](/filings/0001558370-24-005567.md) | [3,927](/filings/0001558370-24-010016.md) | [4,043](/filings/0001558370-24-013506.md) | [4,107](/filings/0001104659-26-018013.md) | [4,125](/filings/0001558370-25-005531.md) | [4,256](/filings/0001558370-25-009525.md) | [4,373](/filings/0001104659-25-101474.md) | [4,383](/filings/0001104659-26-117864.md) | [4,605](/filings/0001104659-26-048474.md) | [4,661](/filings/0001104659-26-086576.md) | [4,749](/filings/0001104659-26-117864.md) |
| Long-term debt | $m | [100](/filings/0001558370-24-013506.md) | [100](/filings/0001558370-24-005567.md) | [100](/filings/0001558370-24-010016.md) | [100](/filings/0001558370-24-013506.md) | [100](/filings/0001104659-25-101474.md) | [100](/filings/0001558370-25-005531.md) | [100](/filings/0001558370-25-009525.md) | [100](/filings/0001104659-25-101474.md) | not reported | [297](/filings/0001104659-26-048474.md) | [297](/filings/0001104659-26-086576.md) | [297](/filings/0001104659-26-117864.md) |
| Short-term borrowings | $m | [100](/filings/0001558370-25-001301.md) | not reported | not reported | not reported | [100](/filings/0001104659-26-018013.md) | not reported | not reported | not reported | [100](/filings/0001104659-26-117864.md) | [50.0](/filings/0001104659-26-048474.md) | not reported | not reported |
| Shareholders' equity | $m | [1,414](/filings/0001104659-26-018013.md) | [1,521](/filings/0001104659-25-101474.md) | [1,585](/filings/0001104659-25-101474.md) | [1,748](/filings/0001104659-25-101474.md) | [1,522](/filings/0001104659-26-117864.md) | [1,604](/filings/0001104659-26-117864.md) | [1,735](/filings/0001104659-26-117864.md) | [1,874](/filings/0001104659-26-117864.md) | [1,778](/filings/0001104659-26-117864.md) | [1,796](/filings/0001104659-26-117864.md) | [1,752](/filings/0001104659-26-117864.md) | [1,696](/filings/0001104659-26-117864.md) |

- Cash and equivalents: us-gaap:Cash
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [122 d](/filings/0001104659-26-018013.md) | [70.9](/filings/0001558370-25-005531.md) | [142 d](/filings/0001558370-25-009525.md) | [219 d](/filings/0001104659-25-101474.md) | [128 d](/filings/0001104659-26-018013.md) | [104](/filings/0001104659-26-048474.md) | [175 d](/filings/0001104659-26-086576.md) | [179 d](/filings/0001104659-26-117864.md) | [157 d](/filings/0001104659-26-018013.md) | [42.8](/filings/0001104659-26-048474.md) | [145 d](/filings/0001104659-26-086576.md) | [195 d](/filings/0001104659-26-117864.md) |
| Capital expenditure | $m | [0.5 d](/filings/0001104659-26-018013.md) | [1.1](/filings/0001558370-25-005531.md) | [2.8 d](/filings/0001558370-25-009525.md) | [0.3 d](/filings/0001104659-25-101474.md) | [0.5 d](/filings/0001104659-26-018013.md) | [1.1](/filings/0001104659-26-048474.md) | [1.3 d](/filings/0001104659-26-086576.md) | [1.4 d](/filings/0001104659-26-117864.md) | [1.8 d](/filings/0001104659-26-018013.md) | [1.1](/filings/0001104659-26-048474.md) | [2.8 d](/filings/0001104659-26-086576.md) | [2.3 d](/filings/0001104659-26-117864.md) |
| Dividends paid | $m | [104 d](/filings/0001104659-26-018013.md) | [12.3](/filings/0001558370-25-005531.md) | [13.3 d](/filings/0001558370-25-009525.md) | [13.3 d](/filings/0001104659-25-101474.md) | [197 d](/filings/0001104659-26-018013.md) | [13.8](/filings/0001104659-26-048474.md) | [14.7 d](/filings/0001104659-26-086576.md) | [14.7 d](/filings/0001104659-26-117864.md) | [198 d](/filings/0001104659-26-018013.md) | [14.7](/filings/0001104659-26-048474.md) | [201 d](/filings/0001104659-26-086576.md) | [16.5 d](/filings/0001104659-26-117864.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [6.3 d](/filings/0001104659-26-117864.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [46.0](/filings/0001558370-24-005567.md) | [46.0](/filings/0001558370-24-010016.md) | [46.1](/filings/0001558370-24-013506.md) | [92.3](/filings/0001558370-25-005531.md) | [92.4](/filings/0001558370-25-009525.md) | [92.4](/filings/0001104659-25-101474.md) | [92.5](/filings/0001104659-26-048474.md) | [92.5](/filings/0001104659-26-086576.md) | [92.3](/filings/0001104659-26-117864.md) | [92.2](/filings/0001104659-26-048474.md) | [92.2](/filings/0001104659-26-086576.md) | [92.3](/filings/0001104659-26-117864.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 91,732,032 at 2026-10-14, from the cover of the [10-Q filed 2026-10-21](/filings/0001104659-26-117864.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:20 ET. No prices; not investment advice.